Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Dentomaxillofac Radiol ; 41(1): 55-63, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22116119

RESUMO

OBJECTIVE: The aim of this study was to investigate the signal intensity characteristics of highly invasive and highly metastasizing transplanted human squamous cell carcinoma using ultra-small super-paramagnetic iron oxide (USPIO)-enhanced MRI and to correlate them with USPIO distribution to tumour components revealed by histological examination. METHODS: 13 nude mice with transplanted human squamous cell carcinoma in the oral cavity were imaged before and 24 hours after intravenous administration of USPIO. The difference in signal intensity between pre-contrast and post-contrast MR images was visually evaluated. For quantitative analysis, signal intensity within a region of interest was measured. Histological findings were correlated with MR findings. The approximate USPIO concentration was evaluated using USPIO phantoms. RESULTS: Seven tumours had an area showing signal intensity increase on post-contrast T1 weighted images. Histopathologically, six of those tumours contained a small amount of iron particles in the stroma. The USPIO concentration was presumed low. Two tumours had an area showing signal intensity decrease on post-contrast T1 and T2 weighted images. The areas had a large amount of iron particles in the stroma and the USPIO concentration was presumed high. There was a minimal amount of iron particles in tumour parenchymal cells. CONCLUSIONS: The amount of USPIO accumulation into tumour stroma was considered to affect MR signal intensity. A small amount increases T1 weighted signal intensity, whereas a large amount decreases T1 and T2 weighted intensity. The USPIO accumulation into the tumour parenchyma was not thought to affect MR signal intensity.


Assuntos
Carcinoma de Células Escamosas/diagnóstico por imagem , Meios de Contraste , Dextranos , Aumento da Imagem/métodos , Imageamento por Ressonância Magnética/métodos , Nanopartículas de Magnetita , Transplante de Neoplasias/diagnóstico por imagem , Neoplasias da Língua/diagnóstico por imagem , Animais , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/secundário , Técnicas de Cultura de Células , Linhagem Celular Tumoral , Tecido Conjuntivo/diagnóstico por imagem , Tecido Conjuntivo/patologia , Meios de Contraste/administração & dosagem , Meios de Contraste/normas , Dextranos/administração & dosagem , Dextranos/normas , Humanos , Processamento de Imagem Assistida por Computador/métodos , Injeções Intravenosas , Nanopartículas de Magnetita/administração & dosagem , Nanopartículas de Magnetita/normas , Camundongos , Camundongos Nus , Invasividade Neoplásica , Transplante de Neoplasias/patologia , Imagens de Fantasmas/normas , Radiografia , Padrões de Referência , Neoplasias da Língua/patologia
2.
Vestn Khir Im I I Grek ; 158(4): 65-7, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10533227

RESUMO

An analysis of biological properties of blood substitutes has shown the expedience of wider clinical use instead of polyglucin of such substitutes as polyglucol, polifer, rondex, neorondex, polyoxidin, volecam; instead of rheopolyglucin--the rheopolyglucin with glucose, rheogluman and rheoglusol prepared for clinical tests; instead of haemodesin--haemodesin-H, neohaemodesin, gluconeodesin; instead of protein hydrolysates--polyamine and purified from peptides infusamine, hydromine, amicin; instead of 0.9% solution of sodium chloride--disol, quintasol, lactasol, mafusol. They have polyfunctional properties and considerably increase the effectiveness of the infusion--transfusion therapy.


Assuntos
Substitutos Sanguíneos , Substitutos Sanguíneos/normas , Substitutos Sanguíneos/uso terapêutico , Dextranos/normas , Dextranos/uso terapêutico , Combinação de Medicamentos , Formiatos/normas , Formiatos/uso terapêutico , Humanos , Manitol/normas , Manitol/uso terapêutico , Substitutos do Plasma/normas , Substitutos do Plasma/uso terapêutico , Povidona/normas , Povidona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA